These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33522688)

  • 1. Immune-modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model.
    Pervaiz N; Kaur H; Parsad D; Kumar R
    Pigment Cell Melanoma Res; 2021 Sep; 34(5):918-927. PubMed ID: 33522688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune modulatory effects of lenalidomide on the cultured peripheral blood mononuclear cells from vitiligo patients.
    Pervaiz N; Kaur H; Parsad D; Kumar R
    Dermatol Ther; 2020 Nov; 33(6):e14473. PubMed ID: 33124184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
    You S; Cho YH; Byun JS; Shin EC
    Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Effects of Baicalin on Vitiligo Mice.
    Zhu Y; Zhong L; Peng J; Yuan Q; Xu A
    Biol Pharm Bull; 2019 Sep; 42(9):1450-1455. PubMed ID: 31217369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
    Richmond JM; Strassner JP; Zapata L; Garg M; Riding RL; Refat MA; Fan X; Azzolino V; Tovar-Garza A; Tsurushita N; Pandya AG; Tso JY; Harris JE
    Sci Transl Med; 2018 Jul; 10(450):. PubMed ID: 30021889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
    Okada T; Sakamoto T; Ishibashi T; Inomata H
    Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effects of EGCG on vitiligo.
    Zhu Y; Wang S; Lin F; Li Q; Xu A
    Fitoterapia; 2014 Dec; 99():243-51. PubMed ID: 25128425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity.
    Rahimi A; Hossein-Nataj H; Hajheydari Z; Aryanian Z; Shayannia A; Ajami A; Asgarian-Omran H
    Exp Dermatol; 2019 Jun; 28(6):674-681. PubMed ID: 31046170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-cell activation in non-segmental vitiligo.
    Mahmoud F; Abul H; al-Saleh Q; Haines D; Burleson J; Morgan G
    J Dermatol; 1998 Oct; 25(10):637-40. PubMed ID: 9830261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
    Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
    J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative increase in regulatory T cells controls development of vitiligo.
    Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
    J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo.
    Moussavi A; Dearman RJ; Kimber I; Kemeny DM
    Int Arch Allergy Immunol; 1998 Jun; 116(2):116-23. PubMed ID: 9652304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
    Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
    J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant role of innate pro-inflammatory cytokines in vitiligo disease.
    Gholijani N; Yazdani MR; Dastgheib L
    Arch Dermatol Res; 2020 Mar; 312(2):123-131. PubMed ID: 31620869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.
    Lee BN; Gao H; Cohen EN; Badoux X; Wierda WG; Estrov Z; Faderl SH; Keating MJ; Ferrajoli A; Reuben JM
    Cancer; 2011 Sep; 117(17):3999-4008. PubMed ID: 21858802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific IgA response, T-cell subtype and cytokine profile in experimental intravaginal trichomoniasis.
    Paintlia MK; Kaur S; Gupta I; Ganguly NK; Mahajan RC; Malla N
    Parasitol Res; 2002 Apr; 88(4):338-43. PubMed ID: 11999021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens.
    Shi F; Erf GF
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):642-9. PubMed ID: 22113479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.